nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ABCB1—Progesterone—uterine cancer	0.0479	0.265	CbGbCtD
Captopril—REN—posterior vena cava—uterine cancer	0.0461	0.156	CbGeAlD
Captopril—CYP2D6—Progesterone—uterine cancer	0.0452	0.25	CbGbCtD
Captopril—ABCB1—Dactinomycin—uterine cancer	0.038	0.21	CbGbCtD
Captopril—F2—posterior vena cava—uterine cancer	0.0321	0.109	CbGeAlD
Captopril—ABCB1—Etoposide—uterine cancer	0.0215	0.119	CbGbCtD
Captopril—ABCB1—Doxorubicin—uterine cancer	0.0146	0.0809	CbGbCtD
Captopril—CYP2D6—Doxorubicin—uterine cancer	0.0138	0.0762	CbGbCtD
Captopril—MMP2—oviduct—uterine cancer	0.0115	0.0389	CbGeAlD
Captopril—LTA4H—exocrine gland—uterine cancer	0.00936	0.0316	CbGeAlD
Captopril—REN—artery—uterine cancer	0.00829	0.028	CbGeAlD
Captopril—MMP2—artery—uterine cancer	0.00762	0.0258	CbGeAlD
Captopril—REN—exocrine gland—uterine cancer	0.00722	0.0244	CbGeAlD
Captopril—MMP2—exocrine gland—uterine cancer	0.00664	0.0224	CbGeAlD
Captopril—MMP9—artery—uterine cancer	0.00662	0.0224	CbGeAlD
Captopril—F2—artery—uterine cancer	0.00578	0.0195	CbGeAlD
Captopril—LTA4H—myometrium—uterine cancer	0.00519	0.0175	CbGeAlD
Captopril—LTA4H—uterine cervix—uterine cancer	0.00404	0.0136	CbGeAlD
Captopril—REN—myometrium—uterine cancer	0.004	0.0135	CbGeAlD
Captopril—LTA4H—smooth muscle tissue—uterine cancer	0.00392	0.0133	CbGeAlD
Captopril—LTA4H—decidua—uterine cancer	0.00385	0.013	CbGeAlD
Captopril—LTA4H—renal system—uterine cancer	0.00378	0.0128	CbGeAlD
Captopril—MMP2—myometrium—uterine cancer	0.00368	0.0124	CbGeAlD
Captopril—LTA4H—endometrium—uterine cancer	0.00365	0.0123	CbGeAlD
Captopril—LTA4H—mammalian vulva—uterine cancer	0.00353	0.0119	CbGeAlD
Captopril—ACE—artery—uterine cancer	0.00353	0.0119	CbGeAlD
Captopril—LTA4H—uterus—uterine cancer	0.00336	0.0114	CbGeAlD
Captopril—REN—epithelium—uterine cancer	0.00314	0.0106	CbGeAlD
Captopril—REN—smooth muscle tissue—uterine cancer	0.00303	0.0102	CbGeAlD
Captopril—LTA4H—female reproductive system—uterine cancer	0.00302	0.0102	CbGeAlD
Captopril—REN—decidua—uterine cancer	0.00297	0.01	CbGeAlD
Captopril—REN—renal system—uterine cancer	0.00291	0.00985	CbGeAlD
Captopril—MMP2—epithelium—uterine cancer	0.00289	0.00977	CbGeAlD
Captopril—MMP2—uterine cervix—uterine cancer	0.00286	0.00968	CbGeAlD
Captopril—REN—endometrium—uterine cancer	0.00282	0.00953	CbGeAlD
Captopril—MMP2—smooth muscle tissue—uterine cancer	0.00278	0.00941	CbGeAlD
Captopril—LTA4H—female gonad—uterine cancer	0.00275	0.0093	CbGeAlD
Captopril—LTA4H—vagina—uterine cancer	0.00273	0.00925	CbGeAlD
Captopril—MMP2—decidua—uterine cancer	0.00273	0.00923	CbGeAlD
Captopril—MMP2—renal system—uterine cancer	0.00268	0.00906	CbGeAlD
Captopril—MMP2—endometrium—uterine cancer	0.00259	0.00876	CbGeAlD
Captopril—MMP9—epithelium—uterine cancer	0.00251	0.00849	CbGeAlD
Captopril—MMP2—mammalian vulva—uterine cancer	0.00251	0.00847	CbGeAlD
Captopril—MMP9—uterine cervix—uterine cancer	0.00249	0.00842	CbGeAlD
Captopril—MMP9—smooth muscle tissue—uterine cancer	0.00242	0.00818	CbGeAlD
Captopril—MMP2—uterus—uterine cancer	0.00239	0.00807	CbGeAlD
Captopril—MMP9—decidua—uterine cancer	0.00237	0.00802	CbGeAlD
Captopril—REN—female reproductive system—uterine cancer	0.00233	0.00789	CbGeAlD
Captopril—MMP9—renal system—uterine cancer	0.00233	0.00788	CbGeAlD
Captopril—MMP9—endometrium—uterine cancer	0.00225	0.00762	CbGeAlD
Captopril—F2—epithelium—uterine cancer	0.00219	0.00741	CbGeAlD
Captopril—MMP2—female reproductive system—uterine cancer	0.00215	0.00725	CbGeAlD
Captopril—REN—female gonad—uterine cancer	0.00212	0.00718	CbGeAlD
Captopril—MMP9—uterus—uterine cancer	0.00208	0.00702	CbGeAlD
Captopril—F2—renal system—uterine cancer	0.00203	0.00687	CbGeAlD
Captopril—MMP2—female gonad—uterine cancer	0.00195	0.0066	CbGeAlD
Captopril—MMP2—vagina—uterine cancer	0.00194	0.00656	CbGeAlD
Captopril—SLC15A1—epithelium—uterine cancer	0.00187	0.00631	CbGeAlD
Captopril—MMP9—female reproductive system—uterine cancer	0.00187	0.00631	CbGeAlD
Captopril—LTA4H—lymph node—uterine cancer	0.00177	0.00598	CbGeAlD
Captopril—SLC15A1—renal system—uterine cancer	0.00173	0.00586	CbGeAlD
Captopril—MMP9—female gonad—uterine cancer	0.0017	0.00574	CbGeAlD
Captopril—SLC15A1—endometrium—uterine cancer	0.00167	0.00566	CbGeAlD
Captopril—F2—female reproductive system—uterine cancer	0.00163	0.00551	CbGeAlD
Captopril—SLC15A1—mammalian vulva—uterine cancer	0.00162	0.00548	CbGeAlD
Captopril—F2—female gonad—uterine cancer	0.00148	0.00501	CbGeAlD
Captopril—ACE—epithelium—uterine cancer	0.00134	0.00453	CbGeAlD
Captopril—ACE—smooth muscle tissue—uterine cancer	0.00129	0.00436	CbGeAlD
Captopril—ACE—decidua—uterine cancer	0.00126	0.00428	CbGeAlD
Captopril—MMP2—lymph node—uterine cancer	0.00126	0.00424	CbGeAlD
Captopril—SLC15A1—vagina—uterine cancer	0.00125	0.00424	CbGeAlD
Captopril—ACE—renal system—uterine cancer	0.00124	0.0042	CbGeAlD
Captopril—ACE—endometrium—uterine cancer	0.0012	0.00406	CbGeAlD
Captopril—ACE—mammalian vulva—uterine cancer	0.00116	0.00393	CbGeAlD
Captopril—MMP9—lymph node—uterine cancer	0.00109	0.00369	CbGeAlD
Captopril—ACE—female reproductive system—uterine cancer	0.000994	0.00336	CbGeAlD
Captopril—ACE—female gonad—uterine cancer	0.000905	0.00306	CbGeAlD
Captopril—ALB—lymph node—uterine cancer	0.000608	0.00206	CbGeAlD
Captopril—CYP2D6—renal system—uterine cancer	0.000608	0.00205	CbGeAlD
Captopril—ABCB1—myometrium—uterine cancer	0.0006	0.00203	CbGeAlD
Captopril—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000591	0.00182	CcSEcCtD
Captopril—Hepatocellular injury—Epirubicin—uterine cancer	0.00059	0.00181	CcSEcCtD
Captopril—Ill-defined disorder—Dactinomycin—uterine cancer	0.00059	0.00181	CcSEcCtD
Captopril—Anaemia—Dactinomycin—uterine cancer	0.000587	0.00181	CcSEcCtD
Captopril—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000585	0.0018	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000583	0.00179	CcSEcCtD
Captopril—ACE—lymph node—uterine cancer	0.000582	0.00197	CbGeAlD
Captopril—Body temperature increased—Progesterone—uterine cancer	0.00058	0.00178	CcSEcCtD
Captopril—Abdominal pain—Progesterone—uterine cancer	0.00058	0.00178	CcSEcCtD
Captopril—Hyperkalaemia—Epirubicin—uterine cancer	0.000579	0.00178	CcSEcCtD
Captopril—Renal failure—Etoposide—uterine cancer	0.000578	0.00178	CcSEcCtD
Captopril—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000578	0.00178	CcSEcCtD
Captopril—Ulcer—Doxorubicin—uterine cancer	0.000577	0.00177	CcSEcCtD
Captopril—Stomatitis—Etoposide—uterine cancer	0.000574	0.00176	CcSEcCtD
Captopril—Jaundice—Etoposide—uterine cancer	0.000574	0.00176	CcSEcCtD
Captopril—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000573	0.00176	CcSEcCtD
Captopril—Malaise—Dactinomycin—uterine cancer	0.000573	0.00176	CcSEcCtD
Captopril—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000569	0.00175	CcSEcCtD
Captopril—Agranulocytosis—Etoposide—uterine cancer	0.000549	0.00169	CcSEcCtD
Captopril—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000548	0.00168	CcSEcCtD
Captopril—Hepatocellular injury—Doxorubicin—uterine cancer	0.000546	0.00168	CcSEcCtD
Captopril—Dry eye—Epirubicin—uterine cancer	0.000545	0.00167	CcSEcCtD
Captopril—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000544	0.00167	CcSEcCtD
Captopril—Myalgia—Dactinomycin—uterine cancer	0.000541	0.00166	CcSEcCtD
Captopril—Hyperkalaemia—Doxorubicin—uterine cancer	0.000536	0.00165	CcSEcCtD
Captopril—Discomfort—Dactinomycin—uterine cancer	0.000534	0.00164	CcSEcCtD
Captopril—Asthenia—Progesterone—uterine cancer	0.000526	0.00162	CcSEcCtD
Captopril—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000526	0.00162	CcSEcCtD
Captopril—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000526	0.00162	CcSEcCtD
Captopril—Pruritus—Progesterone—uterine cancer	0.000519	0.0016	CcSEcCtD
Captopril—Thrombocytopenia—Dactinomycin—uterine cancer	0.000508	0.00156	CcSEcCtD
Captopril—Dry eye—Doxorubicin—uterine cancer	0.000504	0.00155	CcSEcCtD
Captopril—Diarrhoea—Progesterone—uterine cancer	0.000502	0.00154	CcSEcCtD
Captopril—Lymphadenopathy—Epirubicin—uterine cancer	0.000502	0.00154	CcSEcCtD
Captopril—Erythema multiforme—Etoposide—uterine cancer	0.000499	0.00154	CcSEcCtD
Captopril—Anorexia—Dactinomycin—uterine cancer	0.000494	0.00152	CcSEcCtD
Captopril—Diabetes mellitus—Epirubicin—uterine cancer	0.000492	0.00151	CcSEcCtD
Captopril—Flushing—Etoposide—uterine cancer	0.00049	0.00151	CcSEcCtD
Captopril—Photosensitivity—Epirubicin—uterine cancer	0.000487	0.0015	CcSEcCtD
Captopril—CYP2D6—female reproductive system—uterine cancer	0.000487	0.00165	CbGeAlD
Captopril—Dizziness—Progesterone—uterine cancer	0.000485	0.00149	CcSEcCtD
Captopril—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000477	0.00147	CcSEcCtD
Captopril—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000472	0.00145	CcSEcCtD
Captopril—ABCB1—epithelium—uterine cancer	0.000471	0.00159	CbGeAlD
Captopril—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00047	0.00145	CcSEcCtD
Captopril—ABCB1—uterine cervix—uterine cancer	0.000467	0.00158	CbGeAlD
Captopril—Alopecia—Etoposide—uterine cancer	0.000467	0.00144	CcSEcCtD
Captopril—Vomiting—Progesterone—uterine cancer	0.000466	0.00143	CcSEcCtD
Captopril—Lymphadenopathy—Doxorubicin—uterine cancer	0.000464	0.00143	CcSEcCtD
Captopril—Renal failure acute—Epirubicin—uterine cancer	0.000464	0.00143	CcSEcCtD
Captopril—Rash—Progesterone—uterine cancer	0.000463	0.00142	CcSEcCtD
Captopril—Dermatitis—Progesterone—uterine cancer	0.000462	0.00142	CcSEcCtD
Captopril—Headache—Progesterone—uterine cancer	0.00046	0.00141	CcSEcCtD
Captopril—Diabetes mellitus—Doxorubicin—uterine cancer	0.000455	0.0014	CcSEcCtD
Captopril—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000455	0.0014	CcSEcCtD
Captopril—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000454	0.0014	CcSEcCtD
Captopril—Photosensitivity—Doxorubicin—uterine cancer	0.000451	0.00139	CcSEcCtD
Captopril—Decreased appetite—Dactinomycin—uterine cancer	0.000451	0.00139	CcSEcCtD
Captopril—Dysgeusia—Etoposide—uterine cancer	0.00045	0.00138	CcSEcCtD
Captopril—Dermatitis bullous—Epirubicin—uterine cancer	0.000448	0.00138	CcSEcCtD
Captopril—Fatigue—Dactinomycin—uterine cancer	0.000447	0.00137	CcSEcCtD
Captopril—ABCB1—decidua—uterine cancer	0.000445	0.00151	CbGeAlD
Captopril—CYP2D6—female gonad—uterine cancer	0.000443	0.0015	CbGeAlD
Captopril—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000442	0.00136	CcSEcCtD
Captopril—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00044	0.00135	CcSEcCtD
Captopril—ABCB1—renal system—uterine cancer	0.000437	0.00148	CbGeAlD
Captopril—Cerebrovascular accident—Epirubicin—uterine cancer	0.000437	0.00134	CcSEcCtD
Captopril—Nausea—Progesterone—uterine cancer	0.000436	0.00134	CcSEcCtD
Captopril—Hyponatraemia—Epirubicin—uterine cancer	0.00043	0.00132	CcSEcCtD
Captopril—Renal failure acute—Doxorubicin—uterine cancer	0.000429	0.00132	CcSEcCtD
Captopril—Feeling abnormal—Dactinomycin—uterine cancer	0.000427	0.00131	CcSEcCtD
Captopril—Ill-defined disorder—Etoposide—uterine cancer	0.000427	0.00131	CcSEcCtD
Captopril—Anaemia—Etoposide—uterine cancer	0.000425	0.00131	CcSEcCtD
Captopril—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000424	0.0013	CcSEcCtD
Captopril—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000423	0.0013	CcSEcCtD
Captopril—ABCB1—endometrium—uterine cancer	0.000423	0.00143	CbGeAlD
Captopril—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00042	0.00129	CcSEcCtD
Captopril—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000419	0.00129	CcSEcCtD
Captopril—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000419	0.00129	CcSEcCtD
Captopril—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000416	0.00128	CcSEcCtD
Captopril—Malaise—Etoposide—uterine cancer	0.000415	0.00128	CcSEcCtD
Captopril—Dermatitis bullous—Doxorubicin—uterine cancer	0.000414	0.00127	CcSEcCtD
Captopril—Body temperature increased—Dactinomycin—uterine cancer	0.00041	0.00126	CcSEcCtD
Captopril—Abdominal pain—Dactinomycin—uterine cancer	0.00041	0.00126	CcSEcCtD
Captopril—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000409	0.00126	CcSEcCtD
Captopril—ABCB1—mammalian vulva—uterine cancer	0.000409	0.00138	CbGeAlD
Captopril—Cardiac arrest—Epirubicin—uterine cancer	0.000407	0.00125	CcSEcCtD
Captopril—Loss of consciousness—Etoposide—uterine cancer	0.000404	0.00124	CcSEcCtD
Captopril—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000404	0.00124	CcSEcCtD
Captopril—Ataxia—Epirubicin—uterine cancer	0.000402	0.00124	CcSEcCtD
Captopril—Cough—Etoposide—uterine cancer	0.000401	0.00123	CcSEcCtD
Captopril—Hyponatraemia—Doxorubicin—uterine cancer	0.000398	0.00122	CcSEcCtD
Captopril—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000395	0.00121	CcSEcCtD
Captopril—Chest pain—Etoposide—uterine cancer	0.000392	0.0012	CcSEcCtD
Captopril—Orthostatic hypotension—Epirubicin—uterine cancer	0.000391	0.0012	CcSEcCtD
Captopril—ABCB1—uterus—uterine cancer	0.000389	0.00132	CbGeAlD
Captopril—Discomfort—Etoposide—uterine cancer	0.000387	0.00119	CcSEcCtD
Captopril—Confusional state—Etoposide—uterine cancer	0.000378	0.00116	CcSEcCtD
Captopril—Muscular weakness—Epirubicin—uterine cancer	0.000378	0.00116	CcSEcCtD
Captopril—Cardiac arrest—Doxorubicin—uterine cancer	0.000377	0.00116	CcSEcCtD
Captopril—Anaphylactic shock—Etoposide—uterine cancer	0.000375	0.00115	CcSEcCtD
Captopril—Ataxia—Doxorubicin—uterine cancer	0.000372	0.00115	CcSEcCtD
Captopril—Asthenia—Dactinomycin—uterine cancer	0.000372	0.00114	CcSEcCtD
Captopril—Thrombocytopenia—Etoposide—uterine cancer	0.000367	0.00113	CcSEcCtD
Captopril—Tachycardia—Etoposide—uterine cancer	0.000366	0.00113	CcSEcCtD
Captopril—Eosinophilia—Epirubicin—uterine cancer	0.000366	0.00113	CcSEcCtD
Captopril—Pancreatitis—Epirubicin—uterine cancer	0.000363	0.00112	CcSEcCtD
Captopril—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000362	0.00111	CcSEcCtD
Captopril—Angina pectoris—Epirubicin—uterine cancer	0.00036	0.00111	CcSEcCtD
Captopril—Anorexia—Etoposide—uterine cancer	0.000358	0.0011	CcSEcCtD
Captopril—Diarrhoea—Dactinomycin—uterine cancer	0.000355	0.00109	CcSEcCtD
Captopril—Pancytopenia—Epirubicin—uterine cancer	0.000351	0.00108	CcSEcCtD
Captopril—Hypotension—Etoposide—uterine cancer	0.000351	0.00108	CcSEcCtD
Captopril—ABCB1—female reproductive system—uterine cancer	0.00035	0.00118	CbGeAlD
Captopril—Muscular weakness—Doxorubicin—uterine cancer	0.000349	0.00107	CcSEcCtD
Captopril—Neutropenia—Epirubicin—uterine cancer	0.000346	0.00106	CcSEcCtD
Captopril—Pollakiuria—Epirubicin—uterine cancer	0.000342	0.00105	CcSEcCtD
Captopril—Eosinophilia—Doxorubicin—uterine cancer	0.000339	0.00104	CcSEcCtD
Captopril—Photosensitivity reaction—Epirubicin—uterine cancer	0.000338	0.00104	CcSEcCtD
Captopril—Paraesthesia—Etoposide—uterine cancer	0.000337	0.00104	CcSEcCtD
Captopril—Pancreatitis—Doxorubicin—uterine cancer	0.000336	0.00103	CcSEcCtD
Captopril—Weight decreased—Epirubicin—uterine cancer	0.000335	0.00103	CcSEcCtD
Captopril—Dyspnoea—Etoposide—uterine cancer	0.000335	0.00103	CcSEcCtD
Captopril—Somnolence—Etoposide—uterine cancer	0.000334	0.00103	CcSEcCtD
Captopril—Angina pectoris—Doxorubicin—uterine cancer	0.000333	0.00103	CcSEcCtD
Captopril—Vomiting—Dactinomycin—uterine cancer	0.00033	0.00101	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000327	0.00101	CcSEcCtD
Captopril—Rash—Dactinomycin—uterine cancer	0.000327	0.00101	CcSEcCtD
Captopril—Decreased appetite—Etoposide—uterine cancer	0.000326	0.001	CcSEcCtD
Captopril—Pancytopenia—Doxorubicin—uterine cancer	0.000325	0.001	CcSEcCtD
Captopril—Renal failure—Epirubicin—uterine cancer	0.000324	0.000997	CcSEcCtD
Captopril—Fatigue—Etoposide—uterine cancer	0.000324	0.000995	CcSEcCtD
Captopril—Stomatitis—Epirubicin—uterine cancer	0.000322	0.000989	CcSEcCtD
Captopril—Jaundice—Epirubicin—uterine cancer	0.000322	0.000989	CcSEcCtD
Captopril—Constipation—Etoposide—uterine cancer	0.000321	0.000987	CcSEcCtD
Captopril—Neutropenia—Doxorubicin—uterine cancer	0.00032	0.000984	CcSEcCtD
Captopril—ABCB1—female gonad—uterine cancer	0.000319	0.00108	CbGeAlD
Captopril—ABCB1—vagina—uterine cancer	0.000317	0.00107	CbGeAlD
Captopril—Pollakiuria—Doxorubicin—uterine cancer	0.000316	0.000973	CcSEcCtD
Captopril—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000312	0.000961	CcSEcCtD
Captopril—Weight decreased—Doxorubicin—uterine cancer	0.00031	0.000952	CcSEcCtD
Captopril—Feeling abnormal—Etoposide—uterine cancer	0.000309	0.000951	CcSEcCtD
Captopril—Nausea—Dactinomycin—uterine cancer	0.000308	0.000947	CcSEcCtD
Captopril—Agranulocytosis—Epirubicin—uterine cancer	0.000308	0.000947	CcSEcCtD
Captopril—Gastrointestinal pain—Etoposide—uterine cancer	0.000307	0.000944	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000303	0.000931	CcSEcCtD
Captopril—Renal failure—Doxorubicin—uterine cancer	0.0003	0.000923	CcSEcCtD
Captopril—Jaundice—Doxorubicin—uterine cancer	0.000298	0.000915	CcSEcCtD
Captopril—Stomatitis—Doxorubicin—uterine cancer	0.000298	0.000915	CcSEcCtD
Captopril—Rhinitis—Epirubicin—uterine cancer	0.000297	0.000913	CcSEcCtD
Captopril—Abdominal pain—Etoposide—uterine cancer	0.000297	0.000912	CcSEcCtD
Captopril—Body temperature increased—Etoposide—uterine cancer	0.000297	0.000912	CcSEcCtD
Captopril—Hepatitis—Epirubicin—uterine cancer	0.000296	0.000911	CcSEcCtD
Captopril—Pharyngitis—Epirubicin—uterine cancer	0.000294	0.000904	CcSEcCtD
Captopril—Agranulocytosis—Doxorubicin—uterine cancer	0.000285	0.000876	CcSEcCtD
Captopril—Erythema multiforme—Epirubicin—uterine cancer	0.00028	0.000861	CcSEcCtD
Captopril—Flushing—Epirubicin—uterine cancer	0.000275	0.000845	CcSEcCtD
Captopril—Rhinitis—Doxorubicin—uterine cancer	0.000275	0.000845	CcSEcCtD
Captopril—Hepatitis—Doxorubicin—uterine cancer	0.000274	0.000843	CcSEcCtD
Captopril—Pharyngitis—Doxorubicin—uterine cancer	0.000272	0.000836	CcSEcCtD
Captopril—Asthenia—Etoposide—uterine cancer	0.000269	0.000828	CcSEcCtD
Captopril—Pruritus—Etoposide—uterine cancer	0.000266	0.000817	CcSEcCtD
Captopril—Alopecia—Epirubicin—uterine cancer	0.000262	0.000805	CcSEcCtD
Captopril—Erythema multiforme—Doxorubicin—uterine cancer	0.000259	0.000797	CcSEcCtD
Captopril—Diarrhoea—Etoposide—uterine cancer	0.000257	0.00079	CcSEcCtD
Captopril—Flushing—Doxorubicin—uterine cancer	0.000254	0.000782	CcSEcCtD
Captopril—Tension—Epirubicin—uterine cancer	0.000253	0.000778	CcSEcCtD
Captopril—Dysgeusia—Epirubicin—uterine cancer	0.000252	0.000776	CcSEcCtD
Captopril—Nervousness—Epirubicin—uterine cancer	0.00025	0.00077	CcSEcCtD
Captopril—Dizziness—Etoposide—uterine cancer	0.000248	0.000763	CcSEcCtD
Captopril—Vision blurred—Epirubicin—uterine cancer	0.000243	0.000747	CcSEcCtD
Captopril—Alopecia—Doxorubicin—uterine cancer	0.000242	0.000745	CcSEcCtD
Captopril—Ill-defined disorder—Epirubicin—uterine cancer	0.000239	0.000736	CcSEcCtD
Captopril—Vomiting—Etoposide—uterine cancer	0.000239	0.000734	CcSEcCtD
Captopril—Anaemia—Epirubicin—uterine cancer	0.000238	0.000733	CcSEcCtD
Captopril—Rash—Etoposide—uterine cancer	0.000237	0.000728	CcSEcCtD
Captopril—Dermatitis—Etoposide—uterine cancer	0.000236	0.000727	CcSEcCtD
Captopril—Headache—Etoposide—uterine cancer	0.000235	0.000723	CcSEcCtD
Captopril—Tension—Doxorubicin—uterine cancer	0.000234	0.00072	CcSEcCtD
Captopril—Dysgeusia—Doxorubicin—uterine cancer	0.000234	0.000718	CcSEcCtD
Captopril—Malaise—Epirubicin—uterine cancer	0.000232	0.000715	CcSEcCtD
Captopril—Nervousness—Doxorubicin—uterine cancer	0.000232	0.000712	CcSEcCtD
Captopril—Syncope—Epirubicin—uterine cancer	0.000231	0.000711	CcSEcCtD
Captopril—Palpitations—Epirubicin—uterine cancer	0.000228	0.000701	CcSEcCtD
Captopril—Loss of consciousness—Epirubicin—uterine cancer	0.000227	0.000697	CcSEcCtD
Captopril—Cough—Epirubicin—uterine cancer	0.000225	0.000692	CcSEcCtD
Captopril—Vision blurred—Doxorubicin—uterine cancer	0.000225	0.000691	CcSEcCtD
Captopril—Nausea—Etoposide—uterine cancer	0.000223	0.000686	CcSEcCtD
Captopril—Ill-defined disorder—Doxorubicin—uterine cancer	0.000221	0.000681	CcSEcCtD
Captopril—Anaemia—Doxorubicin—uterine cancer	0.00022	0.000678	CcSEcCtD
Captopril—Chest pain—Epirubicin—uterine cancer	0.000219	0.000675	CcSEcCtD
Captopril—Arthralgia—Epirubicin—uterine cancer	0.000219	0.000675	CcSEcCtD
Captopril—Myalgia—Epirubicin—uterine cancer	0.000219	0.000675	CcSEcCtD
Captopril—Discomfort—Epirubicin—uterine cancer	0.000217	0.000667	CcSEcCtD
Captopril—Malaise—Doxorubicin—uterine cancer	0.000215	0.000661	CcSEcCtD
Captopril—Dry mouth—Epirubicin—uterine cancer	0.000215	0.00066	CcSEcCtD
Captopril—Syncope—Doxorubicin—uterine cancer	0.000214	0.000658	CcSEcCtD
Captopril—Confusional state—Epirubicin—uterine cancer	0.000212	0.000652	CcSEcCtD
Captopril—Palpitations—Doxorubicin—uterine cancer	0.000211	0.000648	CcSEcCtD
Captopril—Anaphylactic shock—Epirubicin—uterine cancer	0.00021	0.000647	CcSEcCtD
Captopril—Loss of consciousness—Doxorubicin—uterine cancer	0.00021	0.000645	CcSEcCtD
Captopril—Cough—Doxorubicin—uterine cancer	0.000208	0.00064	CcSEcCtD
Captopril—Shock—Epirubicin—uterine cancer	0.000207	0.000637	CcSEcCtD
Captopril—Thrombocytopenia—Epirubicin—uterine cancer	0.000206	0.000633	CcSEcCtD
Captopril—Tachycardia—Epirubicin—uterine cancer	0.000205	0.000631	CcSEcCtD
Captopril—ABCB1—lymph node—uterine cancer	0.000205	0.000693	CbGeAlD
Captopril—Arthralgia—Doxorubicin—uterine cancer	0.000203	0.000625	CcSEcCtD
Captopril—Chest pain—Doxorubicin—uterine cancer	0.000203	0.000625	CcSEcCtD
Captopril—Myalgia—Doxorubicin—uterine cancer	0.000203	0.000625	CcSEcCtD
Captopril—Discomfort—Doxorubicin—uterine cancer	0.000201	0.000617	CcSEcCtD
Captopril—Anorexia—Epirubicin—uterine cancer	0.000201	0.000617	CcSEcCtD
Captopril—Dry mouth—Doxorubicin—uterine cancer	0.000199	0.000611	CcSEcCtD
Captopril—Hypotension—Epirubicin—uterine cancer	0.000197	0.000605	CcSEcCtD
Captopril—Confusional state—Doxorubicin—uterine cancer	0.000196	0.000604	CcSEcCtD
Captopril—Anaphylactic shock—Doxorubicin—uterine cancer	0.000195	0.000599	CcSEcCtD
Captopril—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000192	0.000589	CcSEcCtD
Captopril—Shock—Doxorubicin—uterine cancer	0.000192	0.000589	CcSEcCtD
Captopril—Thrombocytopenia—Doxorubicin—uterine cancer	0.000191	0.000586	CcSEcCtD
Captopril—Insomnia—Epirubicin—uterine cancer	0.00019	0.000585	CcSEcCtD
Captopril—Tachycardia—Doxorubicin—uterine cancer	0.00019	0.000584	CcSEcCtD
Captopril—Paraesthesia—Epirubicin—uterine cancer	0.000189	0.000581	CcSEcCtD
Captopril—Dyspnoea—Epirubicin—uterine cancer	0.000188	0.000577	CcSEcCtD
Captopril—Somnolence—Epirubicin—uterine cancer	0.000187	0.000575	CcSEcCtD
Captopril—Anorexia—Doxorubicin—uterine cancer	0.000186	0.000571	CcSEcCtD
Captopril—Dyspepsia—Epirubicin—uterine cancer	0.000185	0.00057	CcSEcCtD
Captopril—Decreased appetite—Epirubicin—uterine cancer	0.000183	0.000562	CcSEcCtD
Captopril—Hypotension—Doxorubicin—uterine cancer	0.000182	0.000559	CcSEcCtD
Captopril—Fatigue—Epirubicin—uterine cancer	0.000181	0.000558	CcSEcCtD
Captopril—Constipation—Epirubicin—uterine cancer	0.00018	0.000553	CcSEcCtD
Captopril—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000177	0.000545	CcSEcCtD
Captopril—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000177	0.000892	CbGpPWpGaD
Captopril—Insomnia—Doxorubicin—uterine cancer	0.000176	0.000541	CcSEcCtD
Captopril—Paraesthesia—Doxorubicin—uterine cancer	0.000175	0.000538	CcSEcCtD
Captopril—ALB—Folate Metabolism—CCL2—uterine cancer	0.000174	0.000879	CbGpPWpGaD
Captopril—Dyspnoea—Doxorubicin—uterine cancer	0.000174	0.000534	CcSEcCtD
Captopril—Feeling abnormal—Epirubicin—uterine cancer	0.000173	0.000533	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—TP53—uterine cancer	0.000173	0.000874	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—KRAS—uterine cancer	0.000173	0.000874	CbGpPWpGaD
Captopril—Somnolence—Doxorubicin—uterine cancer	0.000173	0.000532	CcSEcCtD
Captopril—Gastrointestinal pain—Epirubicin—uterine cancer	0.000172	0.000529	CcSEcCtD
Captopril—Dyspepsia—Doxorubicin—uterine cancer	0.000171	0.000527	CcSEcCtD
Captopril—Decreased appetite—Doxorubicin—uterine cancer	0.000169	0.00052	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—KRAS—uterine cancer	0.000169	0.000853	CbGpPWpGaD
Captopril—Fatigue—Doxorubicin—uterine cancer	0.000168	0.000516	CcSEcCtD
Captopril—Constipation—Doxorubicin—uterine cancer	0.000166	0.000512	CcSEcCtD
Captopril—Body temperature increased—Epirubicin—uterine cancer	0.000166	0.000511	CcSEcCtD
Captopril—Abdominal pain—Epirubicin—uterine cancer	0.000166	0.000511	CcSEcCtD
Captopril—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000166	0.000838	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	0.000164	0.000828	CbGpPWpGaD
Captopril—Feeling abnormal—Doxorubicin—uterine cancer	0.00016	0.000493	CcSEcCtD
Captopril—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000159	0.00049	CcSEcCtD
Captopril—F2—Cell surface interactions at the vascular wall—PIK3CA—uterine cancer	0.000159	0.000803	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—SMAD3—uterine cancer	0.000158	0.000798	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKR1B10—uterine cancer	0.000157	0.000792	CbGpPWpGaD
Captopril—MMP2—Axon guidance—VEGFA—uterine cancer	0.000156	0.000786	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—PIK3CA—uterine cancer	0.000155	0.000784	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	0.000154	0.000779	CbGpPWpGaD
Captopril—Abdominal pain—Doxorubicin—uterine cancer	0.000154	0.000473	CcSEcCtD
Captopril—Body temperature increased—Doxorubicin—uterine cancer	0.000154	0.000473	CcSEcCtD
Captopril—MMP2—Axon guidance—NRAS—uterine cancer	0.000154	0.000777	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	0.000152	0.000769	CbGpPWpGaD
Captopril—Asthenia—Epirubicin—uterine cancer	0.000151	0.000464	CcSEcCtD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	0.000149	0.000754	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCL8—uterine cancer	0.000149	0.000751	CbGpPWpGaD
Captopril—Pruritus—Epirubicin—uterine cancer	0.000149	0.000458	CcSEcCtD
Captopril—F2—Cell surface interactions at the vascular wall—HRAS—uterine cancer	0.000147	0.000743	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—NRAS—uterine cancer	0.000145	0.000732	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—ERBB2—uterine cancer	0.000144	0.000728	CbGpPWpGaD
Captopril—Diarrhoea—Epirubicin—uterine cancer	0.000144	0.000443	CcSEcCtD
Captopril—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	0.000144	0.000726	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—HRAS—uterine cancer	0.000144	0.000725	CbGpPWpGaD
Captopril—Asthenia—Doxorubicin—uterine cancer	0.00014	0.00043	CcSEcCtD
Captopril—Dizziness—Epirubicin—uterine cancer	0.000139	0.000428	CcSEcCtD
Captopril—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	0.000138	0.000698	CbGpPWpGaD
Captopril—Pruritus—Doxorubicin—uterine cancer	0.000138	0.000424	CcSEcCtD
Captopril—Vomiting—Epirubicin—uterine cancer	0.000134	0.000411	CcSEcCtD
Captopril—MMP2—Metabolism of proteins—CCL2—uterine cancer	0.000134	0.000674	CbGpPWpGaD
Captopril—Diarrhoea—Doxorubicin—uterine cancer	0.000133	0.00041	CcSEcCtD
Captopril—MMP9—Axon guidance—ERBB2—uterine cancer	0.000133	0.00067	CbGpPWpGaD
Captopril—Rash—Epirubicin—uterine cancer	0.000133	0.000408	CcSEcCtD
Captopril—Dermatitis—Epirubicin—uterine cancer	0.000133	0.000408	CcSEcCtD
Captopril—MMP2—Axon guidance—KRAS—uterine cancer	0.000132	0.000668	CbGpPWpGaD
Captopril—Headache—Epirubicin—uterine cancer	0.000132	0.000405	CcSEcCtD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000132	0.000665	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—FBXW7—uterine cancer	0.000132	0.000664	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RNF43—uterine cancer	0.00013	0.000656	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MET—uterine cancer	0.00013	0.000654	CbGpPWpGaD
Captopril—Dizziness—Doxorubicin—uterine cancer	0.000129	0.000396	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—AKT1—uterine cancer	0.000127	0.00064	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000126	0.000638	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CTNNB1—uterine cancer	0.000126	0.000637	CbGpPWpGaD
Captopril—Nausea—Epirubicin—uterine cancer	0.000125	0.000384	CcSEcCtD
Captopril—F2—Regulation of Actin Cytoskeleton—KRAS—uterine cancer	0.000125	0.00063	CbGpPWpGaD
Captopril—Vomiting—Doxorubicin—uterine cancer	0.000124	0.000381	CcSEcCtD
Captopril—Rash—Doxorubicin—uterine cancer	0.000123	0.000377	CcSEcCtD
Captopril—Dermatitis—Doxorubicin—uterine cancer	0.000123	0.000377	CcSEcCtD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000122	0.000616	CbGpPWpGaD
Captopril—Headache—Doxorubicin—uterine cancer	0.000122	0.000375	CcSEcCtD
Captopril—F2—Signaling Pathways—AKR1B10—uterine cancer	0.000121	0.000612	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CCL2—uterine cancer	0.00012	0.000606	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00012	0.000606	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00012	0.000606	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—INHBA—uterine cancer	0.000119	0.0006	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTEN—uterine cancer	0.000119	0.0006	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EP300—uterine cancer	0.000117	0.000592	CbGpPWpGaD
Captopril—Nausea—Doxorubicin—uterine cancer	0.000116	0.000356	CcSEcCtD
Captopril—F2—Regulation of Actin Cytoskeleton—PIK3CA—uterine cancer	0.000115	0.000579	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000114	0.000576	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	0.000114	0.000573	CbGpPWpGaD
Captopril—LTA4H—Metabolism—EP300—uterine cancer	0.000113	0.000572	CbGpPWpGaD
Captopril—MMP2—Axon guidance—HRAS—uterine cancer	0.000113	0.000568	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	0.000112	0.000566	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—VEGFA—uterine cancer	0.000111	0.000561	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000111	0.00056	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NRAS—uterine cancer	0.00011	0.000554	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	0.000108	0.000546	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.000107	0.000541	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKR1C1—uterine cancer	0.000107	0.000541	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CXCL8—uterine cancer	0.000106	0.000533	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CXCL8—uterine cancer	0.000104	0.000527	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	0.000103	0.000522	CbGpPWpGaD
Captopril—MMP9—Axon guidance—VEGFA—uterine cancer	0.000102	0.000516	CbGpPWpGaD
Captopril—MMP9—Axon guidance—NRAS—uterine cancer	0.000101	0.000509	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RNF43—uterine cancer	0.0001	0.000507	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.0001	0.000505	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	9.99e-05	0.000504	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	9.94e-05	0.000502	CbGpPWpGaD
Captopril—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	9.87e-05	0.000498	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	9.8e-05	0.000494	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CTNNB1—uterine cancer	9.75e-05	0.000492	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL2—uterine cancer	9.62e-05	0.000485	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—VEGFA—uterine cancer	9.59e-05	0.000484	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—PIK3CA—uterine cancer	9.57e-05	0.000483	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CXCL8—uterine cancer	9.5e-05	0.000479	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ERBB2—uterine cancer	9.47e-05	0.000478	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—KRAS—uterine cancer	9.45e-05	0.000477	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	9.31e-05	0.00047	CbGpPWpGaD
Captopril—F2—Signaling Pathways—INHBA—uterine cancer	9.18e-05	0.000464	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	9.13e-05	0.000461	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.81e-05	0.000445	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CTNNB1—uterine cancer	8.76e-05	0.000442	CbGpPWpGaD
Captopril—MMP9—Axon guidance—KRAS—uterine cancer	8.69e-05	0.000438	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	8.56e-05	0.000432	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—VEGFA—uterine cancer	8.48e-05	0.000428	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—uterine cancer	8.45e-05	0.000426	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PIK3CA—uterine cancer	8.39e-05	0.000423	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	8.37e-05	0.000422	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CTNNB1—uterine cancer	8.28e-05	0.000418	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKR1C1—uterine cancer	8.27e-05	0.000417	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKR1C3—uterine cancer	8.24e-05	0.000416	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PGR—uterine cancer	8.03e-05	0.000406	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HRAS—uterine cancer	8.03e-05	0.000405	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	7.92e-05	0.0004	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EP300—uterine cancer	7.7e-05	0.000389	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—YWHAE—uterine cancer	7.66e-05	0.000387	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL8—uterine cancer	7.6e-05	0.000384	CbGpPWpGaD
Captopril—ALB—Hemostasis—IRF1—uterine cancer	7.41e-05	0.000374	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	7.41e-05	0.000374	CbGpPWpGaD
Captopril—ALB—Metabolism—NDUFB11—uterine cancer	7.39e-05	0.000373	CbGpPWpGaD
Captopril—ALB—Metabolism—SRD5A2—uterine cancer	7.39e-05	0.000373	CbGpPWpGaD
Captopril—MMP9—Axon guidance—HRAS—uterine cancer	7.38e-05	0.000373	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FBXW7—uterine cancer	7.35e-05	0.000371	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—uterine cancer	7.29e-05	0.000368	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NRAS—uterine cancer	7.2e-05	0.000364	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.18e-05	0.000362	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—AKT1—uterine cancer	7.09e-05	0.000358	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AKT1—uterine cancer	6.85e-05	0.000346	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—AKT1—uterine cancer	6.84e-05	0.000345	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.78e-05	0.000342	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CCL2—uterine cancer	6.77e-05	0.000342	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NDUFB11—uterine cancer	6.48e-05	0.000327	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SRD5A2—uterine cancer	6.48e-05	0.000327	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STK11—uterine cancer	6.42e-05	0.000324	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKR1C3—uterine cancer	6.37e-05	0.000321	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	6.25e-05	0.000315	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PGR—uterine cancer	6.2e-05	0.000313	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—KRAS—uterine cancer	6.2e-05	0.000313	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SRD5A2—uterine cancer	6.1e-05	0.000308	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NDUFB11—uterine cancer	6.1e-05	0.000308	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SOCS3—uterine cancer	6.01e-05	0.000304	CbGpPWpGaD
Captopril—F2—Signaling Pathways—YWHAE—uterine cancer	5.92e-05	0.000299	CbGpPWpGaD
Captopril—F2—Hemostasis—EP300—uterine cancer	5.83e-05	0.000294	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN2B—uterine cancer	5.76e-05	0.000291	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FBXW7—uterine cancer	5.67e-05	0.000286	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1R—uterine cancer	5.59e-05	0.000282	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—uterine cancer	5.52e-05	0.000279	CbGpPWpGaD
Captopril—F2—Hemostasis—NRAS—uterine cancer	5.46e-05	0.000275	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	5.44e-05	0.000274	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CXCL8—uterine cancer	5.35e-05	0.00027	CbGpPWpGaD
Captopril—ALB—Metabolism—AKR1B1—uterine cancer	5.35e-05	0.00027	CbGpPWpGaD
Captopril—ALB—Metabolism—STAR—uterine cancer	5.35e-05	0.00027	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.28e-05	0.000267	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HRAS—uterine cancer	5.27e-05	0.000266	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SMAD3—uterine cancer	5.26e-05	0.000265	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	5.03e-05	0.000254	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGFR2—uterine cancer	5.01e-05	0.000253	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STK11—uterine cancer	4.96e-05	0.00025	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL2—uterine cancer	4.94e-05	0.000249	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CTNNB1—uterine cancer	4.94e-05	0.000249	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.76e-05	0.00024	CbGpPWpGaD
Captopril—F2—Hemostasis—KRAS—uterine cancer	4.7e-05	0.000237	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKR1B1—uterine cancer	4.68e-05	0.000236	CbGpPWpGaD
Captopril—ABCB1—Metabolism—STAR—uterine cancer	4.68e-05	0.000236	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—uterine cancer	4.65e-05	0.000235	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SOCS3—uterine cancer	4.64e-05	0.000234	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.63e-05	0.000234	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN2B—uterine cancer	4.45e-05	0.000224	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.42e-05	0.000223	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKR1B1—uterine cancer	4.41e-05	0.000223	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—STAR—uterine cancer	4.41e-05	0.000223	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1R—uterine cancer	4.32e-05	0.000218	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CA—uterine cancer	4.31e-05	0.000218	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—uterine cancer	4.3e-05	0.000217	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ESR1—uterine cancer	4.29e-05	0.000217	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	4.25e-05	0.000215	CbGpPWpGaD
Captopril—ALB—Metabolism—POLD1—uterine cancer	4.19e-05	0.000212	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.19e-05	0.000211	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—uterine cancer	4.17e-05	0.000211	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SMAD3—uterine cancer	4.06e-05	0.000205	CbGpPWpGaD
Captopril—F2—Hemostasis—HRAS—uterine cancer	3.99e-05	0.000201	CbGpPWpGaD
Captopril—ALB—Metabolism—AKR1C1—uterine cancer	3.92e-05	0.000198	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—uterine cancer	3.9e-05	0.000197	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGFR2—uterine cancer	3.87e-05	0.000195	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—uterine cancer	3.78e-05	0.000191	CbGpPWpGaD
Captopril—ABCB1—Metabolism—POLD1—uterine cancer	3.68e-05	0.000186	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.56e-05	0.00018	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—uterine cancer	3.52e-05	0.000178	CbGpPWpGaD
Captopril—ALB—Metabolism—RRM2—uterine cancer	3.5e-05	0.000177	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—POLD1—uterine cancer	3.46e-05	0.000175	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKR1C1—uterine cancer	3.44e-05	0.000174	CbGpPWpGaD
Captopril—ALB—Metabolism—DCN—uterine cancer	3.4e-05	0.000171	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	3.32e-05	0.000168	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ESR1—uterine cancer	3.31e-05	0.000167	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.27e-05	0.000165	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKR1C1—uterine cancer	3.24e-05	0.000164	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP11A1—uterine cancer	3.2e-05	0.000161	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.16e-05	0.00016	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—uterine cancer	3.15e-05	0.000159	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—NRAS—uterine cancer	3.13e-05	0.000158	CbGpPWpGaD
Captopril—ABCB1—Metabolism—RRM2—uterine cancer	3.06e-05	0.000155	CbGpPWpGaD
Captopril—ALB—Metabolism—AKR1C3—uterine cancer	3.02e-05	0.000152	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—uterine cancer	2.99e-05	0.000151	CbGpPWpGaD
Captopril—ABCB1—Metabolism—DCN—uterine cancer	2.97e-05	0.00015	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—uterine cancer	2.92e-05	0.000147	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1B—uterine cancer	2.92e-05	0.000147	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—RRM2—uterine cancer	2.89e-05	0.000146	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—DCN—uterine cancer	2.8e-05	0.000141	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP11A1—uterine cancer	2.8e-05	0.000141	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CTNNB1—uterine cancer	2.75e-05	0.000139	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—uterine cancer	2.73e-05	0.000138	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.71e-05	0.000137	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KRAS—uterine cancer	2.69e-05	0.000136	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—uterine cancer	2.69e-05	0.000136	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.67e-05	0.000135	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKR1C3—uterine cancer	2.65e-05	0.000134	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP11A1—uterine cancer	2.64e-05	0.000133	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EP300—uterine cancer	2.56e-05	0.000129	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.49e-05	0.000126	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—uterine cancer	2.48e-05	0.000125	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—uterine cancer	2.43e-05	0.000123	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—uterine cancer	2.43e-05	0.000122	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NRAS—uterine cancer	2.4e-05	0.000121	CbGpPWpGaD
Captopril—ALB—Metabolism—STK11—uterine cancer	2.35e-05	0.000119	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP19A1—uterine cancer	2.35e-05	0.000119	CbGpPWpGaD
Captopril—ALB—Hemostasis—EP300—uterine cancer	2.31e-05	0.000117	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—uterine cancer	2.31e-05	0.000116	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRAS—uterine cancer	2.29e-05	0.000116	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1B—uterine cancer	2.25e-05	0.000114	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—uterine cancer	2.23e-05	0.000112	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.21e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—uterine cancer	2.19e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Hemostasis—NRAS—uterine cancer	2.16e-05	0.000109	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNB1—uterine cancer	2.13e-05	0.000107	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.11e-05	0.000106	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—uterine cancer	2.07e-05	0.000105	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP19A1—uterine cancer	2.06e-05	0.000104	CbGpPWpGaD
Captopril—ABCB1—Metabolism—STK11—uterine cancer	2.06e-05	0.000104	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KRAS—uterine cancer	2.06e-05	0.000104	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—uterine cancer	2.02e-05	0.000102	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EP300—uterine cancer	1.98e-05	9.98e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—STK11—uterine cancer	1.94e-05	9.81e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.94e-05	9.81e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—uterine cancer	1.89e-05	9.56e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—uterine cancer	1.87e-05	9.45e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—KRAS—uterine cancer	1.86e-05	9.4e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NRAS—uterine cancer	1.85e-05	9.34e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—uterine cancer	1.83e-05	9.25e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTHFR—uterine cancer	1.77e-05	8.93e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRAS—uterine cancer	1.75e-05	8.85e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—uterine cancer	1.71e-05	8.64e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—uterine cancer	1.66e-05	8.36e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KRAS—uterine cancer	1.59e-05	8.03e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—HRAS—uterine cancer	1.58e-05	7.99e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.56e-05	7.87e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—uterine cancer	1.55e-05	7.82e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—uterine cancer	1.55e-05	7.81e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—uterine cancer	1.46e-05	7.38e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—uterine cancer	1.46e-05	7.37e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—uterine cancer	1.41e-05	7.14e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—uterine cancer	1.4e-05	7.06e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRAS—uterine cancer	1.35e-05	6.83e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—uterine cancer	1.19e-05	6.03e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—uterine cancer	9.84e-06	4.97e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—EP300—uterine cancer	9.38e-06	4.74e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—uterine cancer	8.62e-06	4.35e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—EP300—uterine cancer	8.22e-06	4.15e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—uterine cancer	8.12e-06	4.1e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—EP300—uterine cancer	7.75e-06	3.91e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—uterine cancer	6.94e-06	3.5e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—uterine cancer	6.08e-06	3.07e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—uterine cancer	5.73e-06	2.89e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—uterine cancer	5.67e-06	2.86e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—uterine cancer	4.97e-06	2.51e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—uterine cancer	4.68e-06	2.36e-05	CbGpPWpGaD
